Royce & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.04M | Sell |
29,000
-13,500
| -32% | -$1.89M | 0.04% | 491 |
|
|
2025
Q4 | $5.22M | Hold |
42,500
| – | – | 0.05% | 457 |
|
|
2025
Q3 | $4.72M | Sell |
42,500
-6,500
| -13% | -$739K | 0.05% | 480 |
|
|
2025
Q2 | $5.43M | Sell |
49,000
-19,000
| -28% | -$2.02M | 0.06% | 444 |
|
|
2025
Q1 | $7.62M | Sell |
68,000
-2,000
| -3% | -$206K | 0.08% | 360 |
|
|
2024
Q4 | $6.47M | Sell |
70,000
-10,000
| -13% | -$900K | 0.06% | 428 |
|
|
2024
Q3 | $6.71M | Hold |
80,000
| – | – | 0.06% | 419 |
|
|
2024
Q2 | $5.49M | Buy |
80,000
+19,000
| +31% | +$1.27M | 0.05% | 457 |
|
|
2024
Q1 | $4.47M | Buy |
61,000
+3,000
| +5% | +$231K | 0.04% | 518 |
|
|
2023
Q4 | $4.7M | Hold |
58,000
| – | – | 0.04% | 503 |
|
|
2023
Q3 | $4.35M | Buy |
58,000
+4,500
| +8% | +$346K | 0.04% | 500 |
|
|
2023
Q2 | $4.12M | Buy |
53,500
+14,500
| +37% | +$1.16M | 0.04% | 542 |
|
|
2023
Q1 | $3.24M | Buy |
39,000
+12,000
| +44% | +$994K | 0.03% | 587 |
|
|
2022
Q4 | $2.32M | Hold |
27,000
| – | – | 0.02% | 626 |
|
|
2022
Q3 | $1.67M | Hold |
27,000
| – | – | 0.02% | 656 |
|
|
2022
Q2 | $1.67M | Buy |
27,000
+5,000
| +23% | +$310K | 0.02% | 685 |
|
|
2022
Q1 | $1.31M | Buy |
+22,000
| New | +$1.41M | 0.01% | 778 |
|
|
2021
Q4 | – | Sell |
-54,500
| Closed | -$3.81M | – | 984 |
|
|
2021
Q3 | $3.81M | Sell |
54,500
-1,500
| -3% | -$105K | 0.03% | 634 |
|
|
2021
Q2 | $3.86M | Buy |
56,000
+500
| +0.9% | +$33.4K | 0.03% | 650 |
|
|
2021
Q1 | $3.59M | Buy |
55,500
+35,500
| +178% | +$2.29M | 0.02% | 666 |
|
|
2020
Q4 | $1.17M | Buy |
+20,000
| New | +$1.21M | 0.01% | 797 |
|
Other funds holding GILD
VCM
VPM
